Sugi Predict

Sugi Predict / Compounds / SCHEMBL4420774

SCHEMBL4420774

SCHEMBL4420774

CCCC[n+]1cc[nH]c1.F[B-](F)(F)F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.35
▸ ADRA2A P08913 2/20 0.35
▸ ADORA3 P0DMS8 2/20 0.35
▸ CHRM1 P11229 2/20 0.35
▸ ACHE P22303 2/20 0.35
▸ SLC6A2 P23975 2/20 0.35
▸ SLC6A4 P31645 2/20 0.35
▸ SLC6A3 Q01959 2/20 0.35
▸ ABCB11 O95342 1/20 0.35
▸ ESR1 P03372 1/20 0.35
▸ PGR P06401 1/20 0.35
▸ HTR1A P08908 1/20 0.35
▸ DRD1 P21728 1/20 0.35
▸ TBXA2R P21731 1/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ OPRM1 P35372 1/20 0.35
▸ DRD3 P35462 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2542757 0.94 CHRM2 (0.42) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL28419528 0.93 CHRM2 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL25206115 0.93 CHRM2 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL28244605 0.93 CHRM2 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL28982033 0.93 CHRM2 (0.46) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL319304 0.92 — —
Iodide SCHEMBL1226159 0.90 SMN1; SMN2 (0.41) CHRM2ADRA2AADORA3CHRM1ACHE
Iodide SCHEMBL1816327 0.90 SMN1; SMN2 (0.41) CHRM2ADRA2AADORA3CHRM1ACHE
Bromide SCHEMBL3469640 0.90 KMT2A (0.42) CHRM2ADRA2AADORA3CHRM1ACHE
SCHEMBL16992935 0.90 CHRM2 (0.39) CHRM2ADRA2AADORA3CHRM1ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205699-B1 Solid state actuation using graphite intercalation compounds HRL LABORATORIES, LLC (US) 2007-04-17 — — US claimed
US-20250387315-A1 Dental Varnishes Based On Cationic Polymer Dispersions IVOCLAR VIVADENT AG (LI) 2025-12-25 — — US disclosed
US-20250387303-A1 Antimicrobial Dental Varnishes Based On Cationic Polymer Dispersions IVOCLAR VIVADENT AG (LI) 2025-12-25 — — US disclosed
US-12442272-B2 Additive manufacture of casing liner in a wellbore SAUDI ARABIAN OIL COMPANY (SA) 2025-10-14 — — US disclosed
US-12392218-B2 Additive manufacture of wellbore tubulars SAUDI ARABIAN OIL COMPANY (SA) 2025-08-19 — — US disclosed
US-20240060390-A1 Additive Manufacture of Wellbore Tubulars SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 — — US disclosed
US-20240060389-A1 Additive Manufacture of Casing Liner in a Wellbore SAUDI ARABIAN OIL COMPANY (SA) 2024-02-22 — — US disclosed
US-11851978-B2 Additive manufacture of casing liner in a wellbore SAUDI ARABIAN OIL COMPANY (SA) 2023-12-26 — — US disclosed
US-11851979-B2 Additive manufacture of wellbore tubulars SAUDI ARABIAN OIL COMPANY (SA) 2023-12-26 — — US disclosed
CN-113620934-B Alkylation method of nitrogen-containing heterocyclic compound in visible light-mediated micro-reaction device 南京先进生物材料与过程装备研究院有限公司 2023-07-07 — — CN disclosed
US-20190169965-A1 Additive Manufacture of Wellbore Lining SAUDI ARABIAN OIL COMPANY (SA) 2019-06-06 — — US disclosed
CN-107532129-A Efficient small volume nucleic acid synthesis 生命技术公司 2018-01-02 — — CN disclosed
US-9207515-B2 Variable-emittance electrochromic devices and methods of preparing the same ASHWIN-USHAS CORPORATION, INC. (US) 2015-12-08 — — US disclosed
US-20140268283-A1 VARIABLE-EMITTANCE ELECTROCHROMIC DEVICES AND METHODS OF PREPARING THE SAME ASHWIN-USHAS CORPORATION, INC. (US) 2014-09-18 — — US disclosed
CN-101679292-B Ionic liquid and method for producing the same NIPPON CHEMICALS 2012-11-14 — — CN disclosed
CN-101679292-A Ionic liquid and method for producing the same NIPPOH CHEMICALS (JP) 2010-03-24 — — CN disclosed
EP-2015638-A2 TRIARYL SUBSTITUTED IMIDAZOLE DERIVATIVES AND TASTE-INHIBITING USES THEREOF Redpoint Bio Corporation (US) 2009-01-21 — — EP disclosed
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof REDPOINT BIO CORPORATION 2007-11-08 — — US disclosed
WO-2007127479-A2 TRIARYL SUBSTITUTED IMIDAZOLE DERIVATIVES AND TASTE-INHIBITING USES THEREOF REDPOINT BIO CORPORATION (US) 2007-11-08 — — WO disclosed
WO-2004035542-A1 FUNCTIONALISED IONIC LIQUIDS AND METHOD FOR THE PRODUCTION THEREOF SOLVENT INNOVATION GMBH (DE) 2004-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250387315-A1 Dental Varnishes Based On Cationic Polymer Dispersions TUBA3C, DNMT1, TUBA1A CHRM2 1024/4885ADRA2A 1315/4885ADORA3 581/4885
US-20070259875-A1 Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof TAS1R3, TAS2R1, TAS1R1 CHRM2 1625/4885ADRA2A 252/4885ADORA3 49/4885
US-20250387303-A1 Antimicrobial Dental Varnishes Based On Cationic Polymer Dispersions TAS2R10, TAS2R40, TAS2R41 CHRM2 1841/4885ADRA2A 2170/4885ADORA3 1391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.